GEOVAX LABS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
GEOVAX LABS, INC. (GOVX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 266.20 thousand shares for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-09-17
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was -773.09K shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 805.30K shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 200.00K shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.10M shares, a 204.33% increase from fiscal 2021.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 360.30K shares, a 40.15% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 266.20K shares S-1 · filed 2026-09-17 | |||
| 2025-12-31 | -773.09K shares derived: S-1 12 month − 10-Q 9 month · filed 2026-09-17 | -773.09K shares derived: sum of 2 quarters · filed 2026-09-17 | -773.09K shares derived: sum of 3 quarters · filed 2026-09-17 | 32.21K shares S-1 · filed 2026-09-17 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-13 | 805.30K shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-28 | 805.30K shares 10-Q · filed 2025-07-28 | ||
| 2025-03-31 | 805.30K shares 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | 200.00K shares 10-K · filed 2025-03-27 | |||
| 2023-12-31 | 0.00 shares 10-K · filed 2024-02-29 | |||
| 2022-12-31 | 1.10M shares 10-K · filed 2023-03-23 | |||
| 2021-12-31 | 360.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | 360.30K shares derived: sum of 2 quarters · filed 2022-03-09 | 360.30K shares derived: sum of 3 quarters · filed 2022-03-09 | 360.30K shares 10-K · filed 2022-03-09 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-12 | 0.00 shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 0.00 shares 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 602.00K shares 10-K · filed 2021-03-23 | |||
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-23 | |||
| 2018-12-31 | 4.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | 7.93M shares 10-K · filed 2019-03-26 | ||
| 2018-09-30 | 3.00M shares 10-Q · filed 2018-11-08 | |||
| 2017-12-31 | 3.68M shares 10-K · filed 2018-03-23 | |||
| 2016-12-31 | 1.79M shares 10-K · filed 2017-03-24 | |||
| 2015-12-31 | 549.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | 564.00K shares derived: sum of 2 quarters · filed 2016-03-16 | 564.00K shares derived: sum of 3 quarters · filed 2016-03-16 | 590.40K shares 10-K · filed 2016-03-16 |
| 2015-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 15.00K shares derived: sum of 2 quarters · filed 2015-11-12 | 41.40K shares 10-Q · filed 2015-11-12 | 251.40K shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | 26.40K shares 10-Q · filed 2015-08-04 | 236.40K shares derived: sum of 3 quarters · filed 2015-08-04 | 236.40K shares derived: sum of 4 quarters · filed 2015-08-04 |
| 2015-03-31 | 26.40K shares 10-Q · filed 2015-05-14 | 236.40K shares derived: sum of 2 quarters · filed 2015-05-14 | 236.40K shares derived: sum of 3 quarters · filed 2015-05-14 | |
| 2014-12-31 | 210.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-20 | 210.00K shares derived: sum of 2 quarters · filed 2015-03-20 | 217.50K shares 10-K · filed 2015-03-20 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 7.50K shares 10-Q · filed 2014-11-12 | ||
| 2014-06-30 | 7.50K shares 10-Q · filed 2014-08-08 | |||
| 2013-12-31 | 210.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | 210.00K shares derived: sum of 2 quarters · filed 2014-03-14 | 210.00K shares derived: sum of 3 quarters · filed 2014-03-14 | 210.00K shares 10-K · filed 2014-03-14 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-12 | 0.00 shares 10-Q · filed 2013-11-12 | |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | 0.00 shares 10-Q · filed 2013-08-12 | ||
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-01 | |||
| 2012-12-31 | 238.50K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |